These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 1321895)

  • 1. Phase II trials of small-cell lung cancer.
    Korn EL; Simon R; Friedman MA; Moore TD
    J Clin Oncol; 1992 Aug; 10(8):1369-70. PubMed ID: 1321895
    [No Abstract]   [Full Text] [Related]  

  • 2. Identification of new drugs in small cell lung cancer: phase II agents first?
    Aisner J
    Cancer Treat Rep; 1987 Dec; 71(12):1131-3. PubMed ID: 2825989
    [No Abstract]   [Full Text] [Related]  

  • 3. Phase II trial of streptozotocin for small cel anaplastic carcinoma of the lung.
    Kane RC; Bernath AM; Cashdollar MR
    Cancer Treat Rep; 1978 Mar; 62(3):477-8. PubMed ID: 206360
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II trials in small-cell lung cancer: shouldn't we be doing better?
    Grant SC; Kris MG
    J Natl Cancer Inst; 1992 Jul; 84(14):1058-9. PubMed ID: 1320130
    [No Abstract]   [Full Text] [Related]  

  • 5. Phase II trial design considerations for small-cell lung cancer.
    Moore TD; Korn EL
    J Natl Cancer Inst; 1992 Feb; 84(3):150-4. PubMed ID: 1311772
    [No Abstract]   [Full Text] [Related]  

  • 6. Phase II evaluation of aclarubicin in lung cancer: a Southeastern Cancer Study Group Trial.
    Kramer BS; Birch R; Gockerman JP; Greco A; Prestridge K
    Cancer Treat Rep; 1986 Jun; 70(6):803-4. PubMed ID: 3015404
    [No Abstract]   [Full Text] [Related]  

  • 7. Chemotherapy for adenocarcinoma and large cell anaplastic carcinoma of the lung with ftorafur, adriamycin, and cis-dichlorodiammineplatinum(II).
    Issell BF; Valdivieso M; Bodey GP
    Cancer Treat Rep; 1978 Jul; 62(7):1089-91. PubMed ID: 210943
    [No Abstract]   [Full Text] [Related]  

  • 8. Combination chemotherapy with vindesine and cisplatin for refractory small cell bronchogenic carcinoma.
    Chiuten DF; Carr DT; Dhingra HM; Murphy WK; Spitzer G; Umsawasdi T; Bodey GP; Valdivieso M
    Cancer Treat Rep; 1986 Jun; 70(6):795-6. PubMed ID: 3015403
    [No Abstract]   [Full Text] [Related]  

  • 9. Phase II evaluation of amsacrine in small cell lung cancer: a Southeastern Cancer Study Group trial.
    Kramer BS; Birch R; Einhorn L; Greco A
    Cancer Treat Rep; 1985 Mar; 69(3):333-4. PubMed ID: 2983895
    [No Abstract]   [Full Text] [Related]  

  • 10. Phase II trial of mitoxantrone as first-line chemotherapy for extensive small cell lung cancer.
    Malik ST; Rayner H; Fletcher J; Slevin ML
    Cancer Treat Rep; 1987 Dec; 71(12):1291-2. PubMed ID: 2825993
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of small cell lung cancer with 6-mercaptopurine: a phase II study.
    Hansen SW; Skovsgaard T; Sørensen JB
    Cancer Treat Rep; 1985 May; 69(5):555. PubMed ID: 2988775
    [No Abstract]   [Full Text] [Related]  

  • 12. Phase II trial of etoposide in previously treated small cell carcinoma of the lung.
    Antman K; Pomfret E; Karp G; Skarin A; Canellos G
    Cancer Treat Rep; 1984 Nov; 68(11):1413-4. PubMed ID: 6094004
    [No Abstract]   [Full Text] [Related]  

  • 13. Phase II clinical trial with bisantrene in patients with advanced refractory small cell lung cancer.
    Myers JW; Von Hoff DD; Clark GM; Coltman CA
    Cancer Treat Rep; 1984 Jun; 68(6):927-8. PubMed ID: 6329511
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of oat cell metastazing bronchial carcinoma with isofosfamide. Results of a prospective randomized study].
    Kokron O
    Osterr Z Onkol; 1974; (5-6):123-7. PubMed ID: 4377798
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical trials referral resource. NCI-Navy: small cell lung cancer.
    Cheson BD
    Oncology (Williston Park); 1990 Sep; 4(9):129-30. PubMed ID: 2169844
    [No Abstract]   [Full Text] [Related]  

  • 16. [Phase II study of etoposide in patients with lung cancer, with special reference to small cell carcinoma].
    Kurita Y; Yokoyama A; Kinameri K; Matsuura N; Sano K
    Nihon Gan Chiryo Gakkai Shi; 1986 Feb; 21(1):108-11. PubMed ID: 3009665
    [No Abstract]   [Full Text] [Related]  

  • 17. Phase II study of mitomycin in small cell lung carcinoma.
    McHale MS; Einhorn LH
    Cancer Treat Rep; 1986 May; 70(5):675. PubMed ID: 3011261
    [No Abstract]   [Full Text] [Related]  

  • 18. Small cell lung cancer trials in the EORTC.
    van Zandwijk N; McVie JG; Dalesio O; Kirkpatrick A
    Eur J Respir Dis Suppl; 1987; 149():57-62. PubMed ID: 3034650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II evaluation of triazinate in patients with metastatic lung cancer.
    Creagan ET; Eagan RT; Fleming TR; Frytak S; Ingle JN; Kvols LK; Nichols WC
    Cancer Treat Rep; 1980; 64(10-11):1057-9. PubMed ID: 6257389
    [No Abstract]   [Full Text] [Related]  

  • 20. Multicenter Phase II trial of etoposide in refractory small cell lung cancer.
    Issell BF; Einhorn LH; Comis RL; Lawson RD; Baker LH; Harvey HA; Lanzotti VA; Wampler GL; Daniels JR; Anderson PN
    Cancer Treat Rep; 1985 Jan; 69(1):127-8. PubMed ID: 2981617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.